2,5-Di-substituted 4-oxazolealkanoic acids and esters
    1.
    发明授权
    2,5-Di-substituted 4-oxazolealkanoic acids and esters 失效
    2,5-二取代的4-氧杂唑酮酸和酯

    公开(公告)号:US4053478A

    公开(公告)日:1977-10-11

    申请号:US748450

    申请日:1976-12-08

    摘要: 2,5-Di-substituted 4-oxazolealkanoic acids and esters thereof of the formula: ##STR1## WHEREIN M REPRESENTS AN INTEGER OF 1 TO 2; R.sup.1 represents an alkyl group having 1 to 4 carbon atoms; n represents an integer of 1 to 2; R represents a mono- or di-substituted phenyl group (in which the substituents are selected from the group consisting of a halogen atom, a methyl group, a methoxy group, a nitro group, a trifluoromethyl group, a phenyl group, a halogen-substituted phenyl group, a phenoxy group and a halogen-substituted phenoxy group), a pyridyl group, a halogen-substituted pyridyl group, a furyl group, a halogen-substituted furyl group, a thienyl group, a halogen-substituted thienyl group, a naphthyl group or a halogen-substituted naphthyl group; when m represents an integer of 1, Y represents an hydrogen atom, an alkyl group having 1 to 2 carbon atoms, a benzyl group or a pyridylmethyl group; and when m represents an integer of 2, Y represents a trimethylene group. These compounds are useful as drugs for the treatment of arteriosclerosis, thrombosis and hypertension with lipid metabolism disorder.

    2,5-Di-substituted 4-oxazolealkanoic acid and esters
    2.
    发明授权
    2,5-Di-substituted 4-oxazolealkanoic acid and esters 失效
    2,5-二取代的4-恶唑烷酸和酯

    公开(公告)号:US4012412A

    公开(公告)日:1977-03-15

    申请号:US557692

    申请日:1975-03-12

    IPC分类号: A61K31/421 C07D263/42

    CPC分类号: C07D263/42 Y10S514/822

    摘要: 2,5-Di-substituted 4-oxazolealkanoic acids and esters thereof of the formula: ##STR1## WHEREIN M REPRESENTS AN INTEGER OF 1 TO 2; R.sup.1 represents an alkyl group having 1 to 4 carbon atoms; n represents an integer of 1 to 2; R represents a mono- or di-substituted phenyl group (in which the substituents are selected from the group consisting of a halogen atom, a methyl group, a methoxy group, a nitro group, a trifluoromethyl group, a phenyl group, a halogen-substituted phenyl group, a phenoxy group and a halogen-substituted phenoxy group), a pyridyl group, a halogen-substituted pyridyl group, a furyl group, a halogen-substituted furyl group, a thienyl group, a halogen-substituted thienyl group, a naphthyl group or a halogen-substituted naphthyl group; when m represents an integer of 1, Y represents an hydrogen atom, an alkyl group having 1 to 2 carbon atoms, a benzyl group or a pyridylmethyl group; and when m represents an integer of 2, Y represents a trimethylene group. These compounds are useful as drugs for the treatment of arteriosclerosis, thrombosis and hypertension with lipid metabolism disorder.

    摘要翻译: 2,5-二取代的4-恶唑烷酸及其酯,具有下式:其中M代表1至2的整数; R1表示碳原子数1〜4的烷基。 n表示1〜2的整数, R表示单取代或二取代的苯基(其中取代基选自卤素原子,甲基,甲氧基,硝基,三氟甲基,苯基, 取代苯基,苯氧基和卤素取代的苯氧基),吡啶基,卤素取代的吡啶基,呋喃基,卤素取代的呋喃基,噻吩基,卤素取代的噻吩基, 萘基或卤素取代的萘基; 当m表示1的整数时,Y表示氢原子,碳原子数1〜2的烷基,苄基或吡啶基甲基。 当m表示2的整数时,Y表示三亚甲基。 这些化合物可用作用于治疗动脉硬化,血栓形成和高血压与脂质代谢紊乱的药物。